---
title: "MPCSH: Vice General Manager Wang Ruoqiang resigned due to work reasons"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/257491353.md"
description: "On September 16th, MPCSH announced that the company's board of directors received a written resignation letter from Deputy General Manager Wang Ruoqiang. Due to work reasons, Wang Ruoqiang applied to resign from the position of Deputy General Manager. Wang Ruoqiang's resignation letter will take effect from the date it is delivered to the company's board of directors. After resigning from the position of Deputy General Manager, Wang Ruoqiang will no longer hold any position in the company or its holding subsidiaries"
datetime: "2025-09-16T07:52:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/257491353.md)
  - [en](https://longbridge.com/en/news/257491353.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/257491353.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/257491353.md) | [繁體中文](https://longbridge.com/zh-HK/news/257491353.md)


# MPCSH: Vice General Manager Wang Ruoqiang resigned due to work reasons

On September 16th, MPCSH announced that the company's board of directors received a written resignation letter from the company's deputy general manager, Wang Ruoqiang. Due to work reasons, Wang Ruoqiang applied to resign from the position of deputy general manager. Wang Ruoqiang's resignation letter will take effect from the date it is delivered to the company's board of directors. After resigning from the position of deputy general manager, Wang Ruoqiang will no longer hold any positions in the company or its holding subsidiaries

### Related Stocks

- [MPCSH (000637.CN)](https://longbridge.com/en/quote/000637.CN.md)

## Related News & Research

- [Junshi Biosciences’ Subcutaneous Toripalimab NDAs Accepted in China](https://longbridge.com/en/news/278445287.md)
- [Bessent, on safe passage of ships in Strait of Hormuz, says U.S. is on track to get this solved](https://longbridge.com/en/news/278171367.md)
- [Kainova Therapeutics reports positive phase 1 results for DT‑9081 in advanced solid tumours](https://longbridge.com/en/news/278526333.md)
- [Top U.S. general: Would look at options if tasked to escort ships in Strait of Hormuz](https://longbridge.com/en/news/278556861.md)
- [17:02 ETEXPLORA JOURNEYS CELEBRATES TRIPLE MARITIME MILESTONE AS LUXURY FLEET EXPANSION ACCELERATES](https://longbridge.com/en/news/278447492.md)